Iranian Journal of Pediatrics

Published by: Kowsar

Role of Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Retinopathy of Prematurity

Binita Goswami 1 , Monika Goyal 2 , Sarita Beri 2 , Rajiv Garg 2 , Arvind Saili 3 and Anju Jain 1
Authors Information
1 Department of Biochemistry, Lady Hardinge Medical College & Associated SSK Hospital, New Delhi, India
2 Department of Ophthalmology, Lady Hardinge Medical College & Associated SSK Hospital, New Delhi, India
3 Department of Pediatrics, Lady Hardinge Medical College & Associated SSK Hospital, New Delhi, India
Warning: No corresponding author defined!
Article information
  • Iranian Journal of Pediatrics: August 28, 2015, 25 (4); e2373
  • Published Online: August 24, 2015
  • Article Type: Research Article
  • Received: December 2, 2014
  • Revised: May 8, 2015
  • Accepted: June 25, 2015
  • DOI: 10.5812/ijp.2373

To Cite: Goswami B, Goyal M, Beri S, Garg R, Saili A, et al. Role of Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Retinopathy of Prematurity, Iran J Pediatr. 2015 ;25(4):e2373. doi: 10.5812/ijp.2373.

Abstract
Copyright © 2015, Growth & Development Research Center.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
References
  • 1. Reynolds JD, Hardy RF, Palmer EA. Incidence and severity of retinopathy of prematurity. J Am Ass Ped Ophthalmol Strabis. 1999; 3(5): 321-2[DOI]
  • 2. Phelps DL. Retinopathy of Prematurity: History, Classification, and Pathophysiology. Neo Rev. 2001; 2(7): 153-66[DOI]
  • 3. Chan-Ling T, Tout S, Hollander H, Stone J. Vascular changes and their mechanisms in the feline model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1992; 33(7): 2128-47[PubMed]
  • 4. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992; 359(6398): 843-5[DOI][PubMed]
  • 5. Pierce EA, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol. 1996; 114(10): 1219-28[PubMed]
  • 6. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med. 1995; 1(10): 1024-8[DOI]
  • 7. Lutty GA, McLeod DS, Merges C, Diggs A, Plouet J. Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol. 1996; 114(8): 971-7[PubMed]
  • 8. International Committee for the Classification of Retinopathy of P. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005; 123(7): 991-9[DOI][PubMed]
  • 9. Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M, et al. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2005; 139(3): 476-81[DOI][PubMed]
  • 10. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, et al. Incidence and Early Course of Retlnonathy of Prematurity. Ophthalmol. 1991; 98(11): 1628-40[DOI]
  • 11. Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989-1997. Pediatrics. 1999; 104(3)[PubMed]
  • 12. Wu WC, Ong FS, Kuo JZ, Lai CC, Wang NC, Chen KJ, et al. Retinopathy of prematurity and maternal age. Retina. 2010; 30(2): 327-31[DOI][PubMed]
  • 13. Holmström G, Thomassen P, Broberger U. Maternal risk factors for retinopathy of prematurity – a population-based study. Acta Obstetricia et Gynecologica Scandinavica. 1996; 75(7): 628-35[DOI]
  • 14. Kim TI, Sohn J, Pi SY, Yoon YH. Postnatal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol. 2004; 18(2): 130-4[PubMed]
  • 15. Allegaert K, de Coen K, Devlieger H, EpiBel Study G. Threshold retinopathy at threshold of viability: the EpiBel study. Br J Ophthalmol. 2004; 88(2): 239-42[PubMed]
  • 16. Ortyl E, Lauterbach R, Starzycka M. [Retinopathy of prematurity: risk factors analysis]. Przegl Lek. 2002; 59 Suppl 1: 91-4[PubMed]
  • 17. Hylander MA, Strobino DM, Dhanireddy R. ASSOCIATION OF RACE, APGAR SCORE AT FIVE MINUTES AND FORMULA FEEDING WITH RETINOPATHY OF PREMATURITY (ROP) AMONG VERY LOW BIRTH WEIGHT (VLBW) INFANTS.† 1181. Pediatr Res. 1997; 41: 199
  • 18. Fledelius HC. Pre-term delivery and subsequent ocular development. Acta Ophthalmol Scandinavica. 2009; 74(3): 297-300[DOI]
  • 19. Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore. 2005; 34(2): 169-78[PubMed]
  • 20. Fortes Filho JB, Eckert GU, Procianoy L, Barros CK, Procianoy RS. Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil. Eye (Lond). 2009; 23(1): 25-30[DOI][PubMed]
  • 21. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004; 25(4): 581-611[DOI][PubMed]
  • 22. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999; 18(14): 3964-72[DOI][PubMed]
  • 23. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995; 1(10): 1024-8[PubMed]
  • 24. Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochemic Biophysic Res Comm. 1991; 181(2): 902-6[DOI]
  • 25. Dulak J, Jozkowicz A, Dembinska-Kiec A, Guevara I, Zdzienicka A, Zmudzinska-Grochot D, et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2000; 20(3): 659-66[PubMed]
  • 26. Pieh C, Agostini H, Buschbeck C, Kruger M, Schulte-Monting J, Zirrgiebel U, et al. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity. Br J Ophthalmol. 2008; 92(5): 689-93[DOI][PubMed]
  • 27. Sonmez K, Drenser KA, Capone AJ, Trese MT. Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity. Ophthalmology. 2008; 115(6): 1065-1070 e1[DOI][PubMed]
  • 28. Azad R, Dave V, Jalali S. Use of intravitreal anti-VEGF: retinopathy of prematurity surgeons' in Hamlet's dilemma? Indian J Ophthalmol. 2011; 59(6): 421-2[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments